Derya Unal
Overview
Explore the profile of Derya Unal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslan A, Demir S, Toprak I, Korkmaz P, Karabacak D, Kahveci N, et al.
Allergy Asthma Proc
. 2025 Feb;
46(2):152-158.
PMID: 40011982
Hypersensitivity reactions (HRs) to iron agents are increasing in parallel with increased use of iron preparations. We aimed to evaluate the clinical features and our previous desensitization protocol in patients...
2.
Microstructure and Release Behavior of Alginate-Natural Hydrocolloid Composites: A Comparative Study
Sicramaz H, Donmez A, Guven B, Unal D, Asbay E
Polymers (Basel)
. 2025 Feb;
17(4).
PMID: 40006194
This study investigated the effects of combining sodium alginate (ALG) with various natural hydrocolloids on the microstructure and release behaviors of microbeads. The encapsulation solutions were prepared at a 1:1...
3.
Celebi Sozener Z, Oguzulgen I, Ozalp Ates F, Baccioglu A, Argun Baris S, Ediger D, et al.
J Asthma
. 2025 Feb;
:1-11.
PMID: 39932533
Objective: The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess the differences between obese and non-obese patients with asthma. Methods: This research is a...
4.
Arslan B, Turk M, Hayme S, Aydin O, Gokmen D, Koycu Buhari G, et al.
Clin Transl Allergy
. 2025 Jan;
15(1):e70018.
PMID: 39865387
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death. Objective:...
5.
Beyaz S, Erdinc M, Hayme S, Aslan A, Aydin O, Gokmen D, et al.
Allergol Immunopathol (Madr)
. 2025 Jan;
53(1):12-25.
PMID: 39786871
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This...
6.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen I, Soyyigit S, et al.
Respir Med
. 2024 Dec;
236:107883.
PMID: 39617354
Current guidelines recommend adding long-acting muscarinic antagonists (LAMAs) in patients with uncontrolled asthma, despite the use of moderate to high doses of inhaled steroid-long-acting beta agonists (ICS/LABA). This study aims...
7.
Korkmaz P, Demir S, Karabacak D, Unal D, Gelincik A
Allergol Immunopathol (Madr)
. 2024 Nov;
52(6):58-61.
PMID: 39515796
Introduction: A patient was presented with a history of idiopathic recurrent anaphylaxis after administration of Pfizer BioNTech mRNA vaccine, and the attacks were controlled with omalizumab. To our knowledge, this...
8.
Cosgun S, Unal D, Caliskan Kartal A, Bedir O
Cureus
. 2024 Oct;
16(9):e70217.
PMID: 39463500
Background: Hepatosteatosis, which we frequently observe today with change in lifestyle, is often unnoticed, but preventable and reversible; if not prevented, it can lead to serious comorbidities. There is contradicting...
9.
Demir S, Eyice-Karabacak D, Kocaturk E, Unal D, Toprak I, Korkmaz P, et al.
Clin Transl Allergy
. 2024 Feb;
14(3):e12342.
PMID: 38415974
Background: Determination of control level in recurrent angioedema (RAE) is necessary to guide management. Here, we validated a Turkish version of the angioedema control test (AECT) for 4-week (AECT-4wk) and...
10.
Cerci P, Kendirlinan R, Buyukozturk S, Gelincik A, Unal D, Demir S, et al.
Allergol Immunopathol (Madr)
. 2023 Sep;
51(5):84-92.
PMID: 37695234
Background: Hypersensitivity reactions (HSRs) to nonsteroidal anti-inflammatory drugs (NSAIDs) are a significant clinical issue. Several classifications have been proposed to categorize these reactions, including the current European Academy of Allergy...